Simplified Management of Obstructive Sleep Apnea in General Practice

Completed

• Conditions: Obstructive sleep apnea; Respiratory - Sleep apnoea

• Registration Number: ACTRN12608000514303
• Lead Sponsor: ational Health and Medical Research Council

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-10-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Moderate-to-severe obstructive sleep apnea (OSA) - positive on OSA50 screening questionnaire; Epworth sleepiness scale (ESS)>=8 or poorly-controlled hypertension despite 2 or more antihypertensive agents; ApneaLink 3% oxygen desturation index (ODI)>=16

Exclusion Criteria

Body mass index (BMI)>50
Neuromuscular disease
Significant psychiatric disease which would affect patient's ability to comply with study protocol
Cognitive disability that would prevent self management of CPAP
Recent hospitalisation for myocardial infarction (MI), unstable angina, cardiac failure, cerebrovascular accident (CVA) or transient ischemic attack (TIA) in past 3 months, and/or New York Heart Association (NYHA) Class 3 or 4
Moderate-to-severe respiratory disease (documented hypoxia or awake oxygen saturation <92%)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Epworth sleepiness scale[baseline, 3 and 6 months]

Secondary Outcome Measures

Name	Time	Method
Functional Outcomes of Sleep Questionnaire to assess the impact of sleepiness on multiple activities of daily living.[baseline, 3 and 6 months];SF36 questionnaire to assess patients views about their health status[baseline, 3 and 6 months];Sleep Apnea Symptoms Questionnaire (SASQ), eg snoring, daytime sleepiness, morning headaches, libido, witnessed apneas[baseline, 3 and 6 months];Patient satisfaction survey[6 months];Health utilisation and costs using Medical Benefits Scheme and Pharmaceutical Benefits Scheme data from Medicare, and patient's self-report regarding hospital admissions.[6 months];CPAP compliance - objective data to be downloaded from the CPAP device[baseline, 3 months, 6 months];Blood pressure[baseline, 3 and 6 months]